Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.

Front Immunol · 2026 · PMC13201113 · PMID 42206028

Europe PMC DOI

hedged sentences

0.0810

closest p · 1.6× alpha

0.2630

boldest claim

The sentences

showed a trendp = 0.081so close (0.05 < p ≤ 0.1)

Ofatumumab Among leukocyte populations, basophils showed a trend towards an increase (p = 0.081) with no other therapy-associated changes.

also in 53,322 other papers

did not reach statistical significancep = 0.263not close (p > 0.1)

55.4), though this did not reach statistical significance (p = 0.263).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.